β-​D-​erythro-​Pentofuranosyl bromide, 2-​deoxy-​2-​fluoro-​2-​methyl-​, 3,​5-​dibenzoate, (2R)​- – (1233335-84-6)

AZ20, 1233339-22-4, AZ 20, (3R)-4-[2-(1H-indol-4-yl)-6-(1-methylsulfonylcyclopropyl)pyrimidin-4-yl]-3-methylmorpholine, (R)-4-(2-(1H-indol-4-yl)-6-(1-(methylsulfonyl)cyclopropyl)pyrimidin-4-yl)-3-methylmorpholine, 4-[4-(1-methanesulfonylcyclopropyl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-1H-indole, CHEMBL2325697, DTXSID201025598, 1H-Indole, 4-[4-[(3R)-3-methyl-4-morpholinyl]-6-[1-(methylsulfonyl)cyclopropyl]-2-pyrimidinyl]-, 4-{4-[(3r)-3-methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1h-indole, (3R)-4-(2-(1H-indol-4-yl)-6-(1-methylsulfonylcyclopropyl)pyrimidin-4-yl)-3-methylmorpholine, VCD, compound 6 [PMID: 46244454], GTPL8477, SCHEMBL2511931, CHEBI:124915, SCGCBAAYLFTIJU-CQSZACIVSA-N, DTXCID001509861, EX-A1801, IZB33922, BDBM50427326, s7050, AKOS024458534, CCG-268793, CS-1483, AZ20, >=98% (HPLC), NCGC00386311-06, AC-32952, AS-16518, HY-15557, SW219703-1, BRD-K42436189-001-01-2, BRD-K42436189-001-03-8, Q27074665, (3R)-4-[2-(1H-indol-4-yl)-6-(1-methylsulfonylcyclopropyl)pyrimidin-4-yl]-3-methyl-morpholine, 808-402-5